Document is current

Any future updates will be listed below

Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose

Crossref DOI link: https://doi.org/10.1186/s13601-015-0088-1

Published Online: 2015-12-23

Published Print: 2015-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark